Cite
Evaluation of the clinical and histological effectiveness of isoretinoin in the therapy of oral leukoplakia. Ten years of experience: is management still up-to-date and effective?
MLA
G.A. Scardina, et al. Evaluation of the Clinical and Histological Effectiveness of Isoretinoin in the Therapy of Oral Leukoplakia. Ten Years of Experience: Is Management Still up-to-Date and Effective? Jan. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e9fb0a9a24eba4ab7c5f84112de3dba&authtype=sso&custid=ns315887.
APA
G.A. Scardina, Francesco Carini, Emiliano Maresi, Vincenzo Valenza, & Pietro Messina. (2005). Evaluation of the clinical and histological effectiveness of isoretinoin in the therapy of oral leukoplakia. Ten years of experience: is management still up-to-date and effective?
Chicago
G.A. Scardina, Francesco Carini, Emiliano Maresi, Vincenzo Valenza, and Pietro Messina. 2005. “Evaluation of the Clinical and Histological Effectiveness of Isoretinoin in the Therapy of Oral Leukoplakia. Ten Years of Experience: Is Management Still up-to-Date and Effective?,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e9fb0a9a24eba4ab7c5f84112de3dba&authtype=sso&custid=ns315887.